Antibiotherapy at birth in very low birth weight infants before and after the use of interleukin 6 as an infectious biomarker in a tertiary level unit

• Main Authors: Sonia Lareu-Vidal (Author), Gonzalo Solís-Sánchez (Author), María Caunedo-Jiménez (Author), Silvia Martín-Ramos (Author), Marta Costa-Romero (Author), Belén Fernández Colomer (Author)
• Format: Book
• Published: Permanyer, 2021-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Neonatal sepsis is a condition with high mortality and morbidity that contributes to high rates of antibiotic therapy at birth. In addition, very low birth weight newborns (VLBWN) are particularly vulnerable. Interleukin 6 (IL-6) seems to be an early and effective marker that could help...